Sun Pharmaceutical Industries Limited (SUNPHARMA)

Rumour Verification - Regulation 30(11)

Filed: 02 Nov 2026, 20:58 IST Exchange: NSE Category: Regulatory Compliance — Rumour Verification

Clarification on news report about Assam facility: issue relates to August 2026, no new event on Oct 30. Share price movement coincides with Q2FY27 results announcement. No undisclosed material event identified.

Source: Original filing PDF — view on exchange portal

⚡ You're reading this after the fact — subscribers got it instantly

ISA

Indian Stock Alerts BOT

🚨 SUNPHARMA — Quarterly Results

Revenue: ₹2,35,800 Cr (+12% YoY)

PAT: ₹19,200 Cr (+17% YoY)

EBITDA margin: 16.8%

Board declared ₹10/share dividend. Jio adds 8M subs.

📎 bseindia.com/xml-data/...

🎧 Audio summary ready

✓✓ 6:47 PM

🎧

Instant audio summaries2-min AI concall recap delivered with every earnings alert

📊

20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings

🔍

Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically

⚡

Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add SUNPHARMA to your watchlist — all of this, automated.

14-day Pro trial · No credit card · Cancel anytime

More on Sun Pharmaceutical Industries Limited

Important. The summary above is generated automatically from Sun Pharmaceutical Industries Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.